经口机器人手术后存活且未住院天数:262例头颈癌队列研究
该回顾性单中心队列研究基于2013–2018年前瞻性TORS数据库,纳入262例头颈恶性肿瘤患者,用DAOH描述术后12个月内手术与疾病相关并发症。总体DAOH365中位数为357天,肺炎对DAOH365减少影响最大。
要点
- TORS术后总体DAOH365中位数为357天(IQR 351–360)。
- 原发根治性切除者DAOH365中位数359天(IQR 351–361)。
- 肺炎是导致DAOH365减少的最主要原因。
核心结论
- TORS术后总体DAOH365中位数为357天,肺炎是导致DAOH365减少的最主要原因。
研究设计与样本
- 回顾性单中心评估前瞻性TORS数据库,纳入2013–2018年接受治疗的262例头颈恶性肿瘤患者。
- 使用DAOH描述术后前12个月手术与疾病相关并发症。
主要发现
- 262例患者总体DAOH365中位数为357天(IQR 351–360)。
- TORS适应证包括原发根治性切除61%、挽救性切除15%、头颈原发不明癌诊断性检查24%。
- 原发根治性切除者DAOH365中位数359天(IQR 351–361)。
- 挽救性切除者DAOH365中位数348天(IQR 233–355)。
- 原发不明癌诊断性检查者DAOH365中位数357天(IQR 351–361)。
临床怎么用
- 可将DAOH365作为评估TORS术后并发症负担的指标。
- 术后应重视肺炎的预防与管理,以减少DAOH365损失。
局限性
- 回顾性单中心研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Days alive and out of hospital (DAOH) is a validated outcome in clinical trials, since it reflects procedure-associated morbidity and mortality. Transoral robotic surgery (TORS) has become a widely adopted procedure with increasing demand for knowledge and data on morbidity. METHODS: Retrospective single-center assessment of a prospective TORS database comprising patients treated for malignancy between 2013 and 2018 using DAOH to describe procedure- and disease-related morbidity the first 12-postoperative months. RESULTS: For 262 patients, median DAOH365 was 357 days (IQR 351-360). Indications for TORS were (i) primary curative resection (61%), (ii) salvage resection (15%), and (iii) diagnostic work-up of cancer of unknown primary in the head and neck (24%). Median DAOH365 was 359 days (IQR 351-361 days), 348 days (IQR 233-355), and 357 days (351-361), respectively. Pneumonia had the highest impact in DAOH365 reduction. CONCLUSION: Total median DAOH365 after TORS was 357 days. The main cause leading to DAOH365 reduction was pneumonia.
引用
- Larsen MHH, Scott SI, Channir HI, et al. Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer. Head Neck. 2021. PMID: 34605110. doi:10.1002/hed.26880
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。